• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOzempic

Ozempic

Page 7 of 9
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Leadership
Ozempic maker Novo Nordisk has a new goal for its leadership team: Make sure no more than 10% of your staff are stressed
By Orianna Rosa RoyleMarch 22, 2024
Oprah Winfrey
Finance
WeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around
By Amanda GerutMarch 14, 2024
Catherine Howarth, CEO of ShareAction.
Retail
Rebel investors want KitKat maker Nestlé to cut back on junk food—but the fortunes of its Mindful Chef brand suggest customers aren’t ready for a health kick
By Ryan HoggMarch 14, 2024
A person using Ozempic
Retail
Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations
By Ashleigh Furlong and BloombergMarch 13, 2024
tube of wegovy injections
Lifestyle
Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy 
By Prarthana PrakashMarch 8, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
WHO
Health
A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says
By Naomi Kresge, Angela Feliciano and BloombergMarch 1, 2024
Meta CEO and cofounder Mark Zuckerberg
Tech
All the tech layoffs are because AI is like ‘corporate Ozempic’—it trims the fat and you keep the fact you’re using it a secret, says marketing guru Scott Galloway
By Paolo ConfinoFebruary 29, 2024
A man walking in front of Sweetgreen
Retail
Meet the surprise winner of the Ozempic craze: a fast-casual chain selling $18 salads
By Madison Muller and BloombergFebruary 21, 2024
Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
Retail
Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
By Ryan HoggFebruary 8, 2024
Lars Fruergaard Jorgensen holding flashcards and talking
Retail
Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them
By Prarthana PrakashFebruary 5, 2024
Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Retail
Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
By Ryan HoggJanuary 31, 2024
North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
Health
North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
By Simone Foxman, Madison Muller and BloombergJanuary 27, 2024
Ozempic is getting more popular—and more expensive
Health
Ozempic is getting more popular—and more expensive
By Chris MorrisJanuary 18, 2024
1...
  • 5
  • 6
  • 7
  • 8
  • 9
9
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.